Impact of Medicare Price Negotiation of Wegovy

Published on January 20, 2025

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk’s blockbuster weight-loss drug Wegovy. Here’s what Wall Street analysts say about the inclusion: WHAT IT MEANS FOR…

Read Full Article (External Site)